GABA may support body's natural defenses against diabetes 2, UCLA research suggests

UCLA researchers have demonstrated that the over-the-counter dietary supplement GABA may help inhibit development of insulin resistance and glucose intolerance - conditions involved in the development of Type 2 diabetes and metabolic syndrome, which affect millions worldwide.

In this early preclinical study, a team of molecular pharmacologists at UCLA’s Geffen School of Medicine fed supplemental GABA - an amino acid-like molecule that the body produces naturally - to mice that were obese, insulin resistant and in the early stages of Type 2 diabetes.